Table 3.
Results of Meta-regression Analyses on the Covariates of Postintervention Effects (N = 13)
Variable | Coef | Std. Err | t | P >|t| | 95% Interval | |
---|---|---|---|---|---|---|
Cancer type: mixed (referent: breast cancer) | 1.021 | 0.826 | 1.240 | 0.342 | −2.533 | 4.574 |
Cancer Present: yes (referent: no) | 1.047 | 0.285 | 2.179 | 0.037* | 0.167 | 1.926 |
Cancer stage: 0–3 (referent: 2–4) | −0.201 | 0.186 | −1.080 | 0.392 | −1.000 | 0.598 |
Gender: mixed (referent: female) | −0.126 | 0.451 | −0.280 | 0.806 | −2.066 | 1.814 |
Resilience as primary outcome: yes (referent: no) | 0.922 | 0.228 | 4.050 | 0.056 | −0.058 | 1.901 |
Resilience measurement tool: CD-RISC (referent: RS) | 1.590 | 0.491 | 3.240 | 0.084 | −0.522 | 3.701 |
Intervention type: traditional CBT (referent: contemporary CBT) | 0.240 | 0.520 | 0.460 | 0.690 | −1.999 | 2.480 |
CBT delivery: face-to-face (referent: mobile device) | −0.765 | 0.284 | 2.681 | 0.012* | −1.485 | −0.044 |
CBT format: group (referent: individual) | −0.105 | 0.181 | −0.580 | 0.042* | −0.570 | 0.360 |
CBT duration weeks: ≤ 6 weeks (referent: > 6 weeks) | 0.044 | 0.176 | 0.25 | 0.825 | −0.713 | 0.801 |
_cons | −5.225 | 2.552 | −2.047 | 0.018* | −16.206 | 5.756 |
Abbreviations: *P < 0.05